{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:07:06Z","timestamp":1780528026276,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Fund of scientific research innovation of The First Affiliated Hospital of Harbin Medical University","award":["NO.2025M06"],"award-info":[{"award-number":["NO.2025M06"]}]},{"name":"the Fundamental Research Funds for the Provincial Universities in Heilongjiang Province","award":["202507"],"award-info":[{"award-number":["202507"]}]},{"name":"the Health Commission of Heilongjiang","award":["20230909010239"],"award-info":[{"award-number":["20230909010239"]}]},{"name":"Joint Fund of Natural Science Foundation of Heilongjiang Province","award":["PL2025H094"],"award-info":[{"award-number":["PL2025H094"]}]},{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82272053"],"award-info":[{"award-number":["82272053"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01302-1","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:55:20Z","timestamp":1775523320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative susceptibility mapping and MRS-based multimodal machine learning for early Parkinson\u2019s disease classification"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huailei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"1302_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi, F., Bravi, D., Emmi, A. & Antonini, A. Parkinson disease therapy: current strategies and future research priorities. Nat. Rev. Neurol. 20, 695\u2013707 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1302_CR2","doi-asserted-by":"publisher","unstructured":"Su, D. et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952 (2025).","DOI":"10.1136\/bmj-2024-080952"},{"key":"1302_CR3","doi-asserted-by":"crossref","unstructured":"Wang, R. & Shih, L. C. Parkinson\u2019s disease\u2014current treatment. Curr. Opin. Neurol. 36, 302\u2013308 (2023).","DOI":"10.1097\/WCO.0000000000001166"},{"key":"1302_CR4","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC201809040","volume":"169","author":"H Homayoun","year":"2018","unstructured":"Homayoun, H. Parkinson disease. Ann. Intern. Med. 169, ITC33\u2013ITC48 (2018).","journal-title":"Ann. Intern. Med."},{"key":"1302_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s12272-017-0960-8","volume":"40","author":"Y Lee","year":"2017","unstructured":"Lee, Y., Kim, M.-S. & Lee, J. Neuroprotective strategies to prevent and treat Parkinson\u2019s disease based on its pathophysiological mechanism. Arch. Pharm. Res. 40, 1117\u20131128 (2017).","journal-title":"Arch. Pharm. Res."},{"key":"1302_CR6","doi-asserted-by":"publisher","first-page":"1446878","DOI":"10.3389\/fnins.2024.1446878","volume":"18","author":"A-GP Dennis","year":"2024","unstructured":"Dennis, A.-G. P. & Strafella, A. P. The identification of cognitive impairment in Parkinson\u2019s disease using biofluids, neuroimaging, and artificial intelligence. Front. Neurosci. 18, 1446878 (2024).","journal-title":"Front. Neurosci."},{"key":"1302_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf088","volume":"26","author":"X Zhou","year":"2025","unstructured":"Zhou, X. et al. A novel integrative multimodal classifier to enhance the diagnosis of Parkinson\u2019s disease. Brief. Bioinform. 26, bbaf088 (2025).","journal-title":"Brief. Bioinform."},{"key":"1302_CR8","doi-asserted-by":"publisher","unstructured":"Mattia, G. M. et al. Deep learning to differentiate Parkinsonian syndromes using multimodal magnetic resonance imaging: a proof-of-concept study. Mov. Disord. 30300. https:\/\/doi.org\/10.1002\/mds.30300 (2025).","DOI":"10.1002\/mds.30300"},{"key":"1302_CR9","doi-asserted-by":"publisher","first-page":"105728","DOI":"10.1016\/j.neubiorev.2024.105728","volume":"162","author":"AR Thomson","year":"2024","unstructured":"Thomson, A. R., Pasanta, D., Arichi, T. & Puts, N. A. Neurometabolite differences in autism as assessed with magnetic resonance spectroscopy: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 162, 105728 (2024).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1302_CR10","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.21037\/qims-24-1853","volume":"15","author":"S Hu","year":"2025","unstructured":"Hu, S. et al. Test-retest precision of brain metabolites in healthy participants using 31P-MRS and 1H MEGA-PRESS on a 3T multi-nuclear MRI system. Quant. Imaging Med. Surg. 15, 2852\u20132864 (2025).","journal-title":"Quant. Imaging Med. Surg."},{"key":"1302_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","volume":"86","author":"PG Mullins","year":"2014","unstructured":"Mullins, P. G. et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. NeuroImage 86, 43\u201352 (2014).","journal-title":"NeuroImage"},{"key":"1302_CR12","doi-asserted-by":"publisher","first-page":"103661","DOI":"10.1016\/j.nicl.2024.103661","volume":"43","author":"Y Tian","year":"2024","unstructured":"Tian, Y. et al. Unveiling MRI markers for Parkinson\u2019s disease: GABAergic dysfunction and cortical changes. NeuroImage Clin. 43, 103661 (2024).","journal-title":"NeuroImage Clin."},{"key":"1302_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2024.120547","volume":"289","author":"X Guan","year":"2024","unstructured":"Guan, X. et al. Neuroimaging of Parkinson\u2019s disease by quantitative susceptibility mapping. NeuroImage 289, 120547 (2024).","journal-title":"NeuroImage"},{"key":"1302_CR14","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.21037\/qims-24-168","volume":"14","author":"W Guo","year":"2024","unstructured":"Guo, W. et al. Quantitative susceptibility mapping of subcortical iron deposition in Parkinson disease and multiple system atrophy: clinical correlations and diagnostic implications. Quant. Imaging Med. Surg. 14, 4464\u20134474 (2024).","journal-title":"Quant. Imaging Med. Surg."},{"key":"1302_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221143834","volume":"16","author":"F Marxreiter","year":"2023","unstructured":"Marxreiter, F. et al. Parkinson\u2019s disease or multiple system atrophy: potential separation by quantitative susceptibility mapping. Ther. Adv. Neurol. Disord. 16, 17562864221143834 (2023).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1302_CR16","doi-asserted-by":"publisher","unstructured":"Diaz-Galvan, P. et al. Substantia nigra iron deposition in Lewy body disease: a magnetic resonance imaging and neuropathology study. Mov. Disord. 30265. https:\/\/doi.org\/10.1002\/mds.30265 (2025).","DOI":"10.1002\/mds.30265"},{"key":"1302_CR17","doi-asserted-by":"publisher","first-page":"1591605","DOI":"10.3389\/fnins.2025.1591605","volume":"19","author":"H Xiao","year":"2025","unstructured":"Xiao, H. et al. The application of radiomics in the diagnosis and evaluation of cognitive impairment related to neurological diseases. Front. Neurosci. 19, 1591605 (2025).","journal-title":"Front. Neurosci."},{"key":"1302_CR18","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1007\/s00330-022-08790-8","volume":"32","author":"JJ Kang","year":"2022","unstructured":"Kang, J. J. et al. Combining quantitative susceptibility mapping to radiomics in diagnosing Parkinson\u2019s disease and assessing cognitive impairment. Eur. Radio. 32, 6992\u20137003 (2022).","journal-title":"Eur. Radio."},{"key":"1302_CR19","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1002\/alz.13479","volume":"19","author":"SJ Marzi","year":"2023","unstructured":"Marzi, S. J. et al. Artificial intelligence for neurodegenerative experimental models. Alzheimer\u2019s Dement. 19, 5970\u20135987 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1302_CR20","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/bib\/bbaa310","volume":"22","author":"N Burgos","year":"2021","unstructured":"Burgos, N., Bottani, S., Faouzi, J., Thibeau-Sutre, E. & Colliot, O. Deep learning for brain disorders: from data processing to disease treatment. Brief. Bioinform. 22, 1560\u20131576 (2021).","journal-title":"Brief. Bioinform."},{"key":"1302_CR21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1109\/JBHI.2024.3482180","volume":"29","author":"Y Jiang","year":"2025","unstructured":"Jiang, Y., Yang, H.-J., Kim, J., Tang, Z. & Ruan, X. Power of multi-modality variables in predicting Parkinson\u2019s disease progression. IEEE J. Biomed. Health Inform. 29, 1343\u20131356 (2025).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"1302_CR22","doi-asserted-by":"crossref","unstructured":"Yang, N. et al.Motor symptoms of Parkinson\u2019s disease: critical markers for early AI-assisted diagnosis. Front. Aging Neurosci. 17, 1602426 (2025).","DOI":"10.3389\/fnagi.2025.1602426"},{"key":"1302_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.euroneuro.2024.08.005","volume":"88","author":"D Ostojic","year":"2024","unstructured":"Ostojic, D., Lalousis, P. A., Donohoe, G. & Morris, D. W. The challenges of using machine learning models in psychiatric research and clinical practice. Eur. Neuropsychopharmacol. 88, 53\u201365 (2024).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1302_CR24","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/mds.30223","volume":"40","author":"RTJ Loo","year":"2025","unstructured":"Loo, R. T. J. et al. Interpretable machine learning for cross-cohort prediction of motor fluctuations in Parkinson\u2019s disease. Mov. Disord. 40, 1604\u20131617 (2025).","journal-title":"Mov. Disord."},{"key":"1302_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-021-00266-8","volume":"8","author":"J Zhang","year":"2022","unstructured":"Zhang, J. Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson\u2019s disease. npj Parkinsons Dis. 8, 13 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"1302_CR26","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hbm.24857","volume":"41","author":"AJM Van Nuland","year":"2020","unstructured":"Van Nuland, A. J. M. et al. GABAergic changes in the thalamocortical circuit in Parkinson\u2019s disease. Hum. Brain Mapp. 41, 1017\u20131029 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"1302_CR27","doi-asserted-by":"publisher","first-page":"1504733","DOI":"10.3389\/fnagi.2025.1504733","volume":"17","author":"Q Ye","year":"2025","unstructured":"Ye, Q. et al. Individualized diagnosis of Parkinson\u2019s disease based on multivariate magnetic resonance imaging radiomics and clinical indexes. Front. Aging Neurosci. 17, 1504733 (2025).","journal-title":"Front. Aging Neurosci."},{"key":"1302_CR28","doi-asserted-by":"crossref","unstructured":"Hongyi Chen, X. L., Xiao Luo, J. F., Kun Zhou, N. W. & Yuxin Li, D. G. An automated hybrid approach via deep learning and radiomics focused on the midbrain and substantia nigra to detect early-stage Parkinson\u2019s disease. Front. Aging Neurosci.16, 1397896 (2024).","DOI":"10.3389\/fnagi.2024.1397896"},{"key":"1302_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/17562864251318865","volume":"18","author":"Y-H Huang","year":"2025","unstructured":"Huang, Y.-H. et al. Differentiating idiopathic Parkinson\u2019s disease from multiple system atrophy-P using brain MRI-based radiomics: a multicenter study. Ther. Adv. Neurol. Disord. 18, 17562864251318865 (2025).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"1302_CR30","doi-asserted-by":"publisher","unstructured":"Pinamonti, M., Sammassimo, V., Moretto, M. & Veronese, M. Comparison of statistical methods for brain age prediction using neuroimaging data. in 47th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 1\u20136. https:\/\/doi.org\/10.1109\/EMBC58623.2025.11254883 (IEEE, 2025).","DOI":"10.1109\/EMBC58623.2025.11254883"},{"key":"1302_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102247","volume":"212","author":"H Li","year":"2022","unstructured":"Li, H. et al. The role of MRS-assessed GABA in human behavioral performance. Prog. Neurobiol. 212, 102247 (2022).","journal-title":"Prog. Neurobiol."},{"key":"1302_CR32","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.cub.2017.04.055","volume":"27","author":"J Kolasinski","year":"2017","unstructured":"Kolasinski, J. et al. A mechanistic link from GABA to cortical architecture and perception. Curr. Biol. 27, 1685\u20131691.e3 (2017).","journal-title":"Curr. Biol."},{"key":"1302_CR33","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00415-025-12944-1","volume":"272","author":"J Ren","year":"2025","unstructured":"Ren, J. et al. Glymphatic system dysfunction as a biomarker of disease progression in Parkinson\u2019s disease: neuroimaging evidence from longitudinal cohort studies. J. Neurol. 272, 196 (2025).","journal-title":"J. Neurol."},{"key":"1302_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41531-025-01096-8","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. GABA outperforms iron and neuromelanin in detecting nigrostriatal alterations in early-stage Parkinson\u2019s disease with RBD. npj Parkinsons Dis. 11, 229 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"1302_CR35","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/hbm.25798","volume":"43","author":"S Tang","year":"2022","unstructured":"Tang, S. et al. Quantitative susceptibility mapping shows lower brain iron content in children with attention-deficit hyperactivity disorder. Hum. Brain Mapp. 43, 2495\u20132502 (2022).","journal-title":"Hum. Brain Mapp."},{"key":"1302_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fnagi.2019.00106","volume":"11","author":"K Ghassaban","year":"2019","unstructured":"Ghassaban, K. et al. Regional high iron in the substantia nigra differentiates Parkinson\u2019s disease patients from healthy controls. Front. Aging Neurosci. 11, 106 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"1302_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00503-3","volume":"18","author":"A Yaqoob","year":"2025","unstructured":"Yaqoob, A. et al. Optimizing accuracy and dimensionality: a swarm intelligence strategy for robust cancer genomics classification. BioData Min. 18, 79 (2025).","journal-title":"BioData Min."},{"key":"1302_CR38","doi-asserted-by":"publisher","first-page":"1665427","DOI":"10.3389\/fonc.2025.1665427","volume":"15","author":"Z Guo","year":"2025","unstructured":"Guo, Z. et al. Identification of NPM and non-mass breast cancer based on radiological features and radiomics. Front. Oncol. 15, 1665427 (2025).","journal-title":"Front. Oncol."},{"key":"1302_CR39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations the movement disorder society task force on rating scales for Parkinson\u2019s disease. Mov. Disord. 19, 1020\u20131028 (2004).","journal-title":"Mov. Disord."},{"key":"1302_CR40","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.3390\/cancers13123000","volume":"13","author":"Y Li","year":"2021","unstructured":"Li, Y., Ammari, S., Balleyguier, C., Lassau, N. & Chouzenoux, E. Impact of preprocessing and harmonization methods on the removal of scanner effects in brain MRI radiomic features. Cancers 13, 3000 (2021).","journal-title":"Cancers"},{"key":"1302_CR41","first-page":"1","volume":"2016","author":"X He","year":"2016","unstructured":"He, X., Koo, B.-B. & Killiany, R. J. Edited magnetic resonance spectroscopy detects an age-related decline in nonhuman primate brain GABA Levels. BioMed. Res. Int. 2016, 1\u20137 (2016).","journal-title":"BioMed. Res. Int."},{"key":"1302_CR42","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist, B. G., Hare, D. J. & Double, K. L. Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18, e13031 (2019).","journal-title":"Aging Cell"},{"key":"1302_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino, R. & Schapira, A. H. V. Parkinson disease. Eur. J. Neurol. 27, 27\u201342 (2020).","journal-title":"Eur. J. Neurol."},{"key":"1302_CR44","doi-asserted-by":"publisher","first-page":"116189","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls, E. T., Huang, C.-C., Lin, C.-P., Feng, J. & Joliot, M. Automated anatomical labelling atlas 3. NeuroImage 206, 116189 (2020).","journal-title":"NeuroImage"},{"key":"1302_CR45","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM Van Griethuysen","year":"2017","unstructured":"Van Griethuysen, J. J. M. et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 77, e104\u2013e107 (2017).","journal-title":"Cancer Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01302-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01302-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:29:45Z","timestamp":1780525785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01302-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1302"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01302-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}